Prostate cancer can often be found early by testing the amount of PSA (prostate-specific antigen) in your blood. Another way prostate cancer is found early is when the doctor does a digital rectal exam (DRE). Because the prostate gland lies just in front of the rectum, during the DRE the doctor can feel if there are any bumps or hard places on the prostate. These might be cancer. If you have had routine yearly exams and either one of these test results becomes abnormal, any cancer you might have has probably been found at an early, more treatable stage.

Since about 1990 it has become more common for men to have tests to find prostate cancer early. The prostate cancer death rate has dropped, too. But we do not yet know if this drop is the direct result of the tests.

These tests are not perfect, though. Uncertain or false test results could cause confusion and anxiety. There is no question that the PSA test can help spot prostate cancer. But it can't tell how dangerous the cancer is. The problem is that some prostate cancers are slow-growing and may never cause problems. But because of a high PSA level, many men will be found to have prostate cancer that would never have led to their deaths. Often these men are being treated with either surgery or radiation, either because their doctor can't be sure how fast the cancer might spread or because they are uncomfortable not having treatment. Doctors and patients are still struggling to decide who should get treatment and who can be followed without treatment.

Until more is known, you should talk to your doctor about whether or not you want to be tested. Things to take into account are your age and your health. If you are young and you get prostate cancer, it will probably shorten your life if it is not caught early. But if you are older or in poor health, then prostate cancer may never become a major problem because it often grows so slowly.

What the American Cancer Society recommends

The American Cancer Society believes that doctors should offer the PSA blood test and DRE (digital rectal exam) yearly, beginning at age 50, to men who can be expected to live at least 10 more years. Men at high risk should begin testing at age 45. Men at high risk include African American men and men who have a close relative (father, brother, or son) who had prostate cancer before age 65.

Men at even higher risk (because they have several close relatives with prostate cancer at an early age) could begin testing at age 40. Depending on the results of the first tests, they might not need more testing until age 45.

Doctors should talk to men about the benefits and risks of testing, and men should take an active part in the choice about whether or not to have tests. Men should also discuss the pros and cons of looking for and treating early prostate cancer before they have the tests.

No major scientific or medical groups (including the American Cancer Society) recommend routine testing for prostate cancer at this time. Many health organizations, including the ACS, recommend that men talk to their doctors about the benefits, risks, side effects, and questions about early prostate cancer tests and treatment. Each man needs to have this information to make the decision that is right for him.

The PSA blood test

PSA (prostate-specific antigen) is a substance made by the prostate gland. Although PSA is mostly found in semen, a small amount is also found in the blood. Most healthy men have levels under 4 ng/mL (nanograms per milliliter) of blood. The chance of having prostate cancer goes up as the PSA level goes up. If your level is between 4 and 10, you have about a 1 in 4 chance of having prostate cancer. If it is above 10, your chance is over 50%. But some men with a PSA below 4 can also have prostate cancer.

Factors other than cancer can also cause the PSA level to go up, including:

• BPH (benign prostatic hyperplasia), a non-cancerous swelling of the prostate that many men get as they grow older.
• Age: PSA levels go up slowly as you get older, even if you have no prostate changes.
• Prostatitis: an infection or inflammation of the prostate gland
• Ejaculation can cause the PSA to go up for a short time, and then go down again.

There are a number of new types of PSA tests that might help to show whether or not you need more testing. Not all doctors agree on how to use these new PSA tests. You should talk to your doctor about your cancer risk and any tests that you are having.

Use of the PSA blood test after prostate cancer diagnosis

Although the PSA test is used mainly to find prostate cancer early, it has other uses, too.

• In men diagnosed with prostate cancer, it can be used along with other results to help decide which types of testing or treatment might be helpful.

• A very high PSA level might mean that the cancer has spread beyond the prostate. This also helps determine treatment because some forms of treatment are not as helpful for cancer that has spread to the lymph nodes or other organs.

• The PSA test can also be used to help show if treatment is working, how well it is working, or whether the cancer has come back after treatment.

• If you choose a "watchful waiting" approach to treatment, the PSA level can be used to help decide whether the cancer is growing and whether active treatment should be considered.

If prostate cancer has come back (recurred) after treatment, or if it has spread outside of the prostate (metastatic disease), the actual PSA number may not be as important as whether it changes. The PSA number does not predict whether or not a person will have symptoms or how long he will live. Many people have very high PSA values and feel just fine. Other people have low values and have symptoms. With advanced disease, it also may be more important to look at the way the PSA level is changing rather than the actual number.

DRE (digital rectal exam)

To do the DRE, the doctor puts a gloved, lubricated finger into the rectum to feel for any irregular or firm areas that might be cancer. The prostate gland is next to the rectum, and most cancers begin in the part of the gland that can be reached by rectal exam. While it is uncomfortable, the exam isn't painful and takes only a short time.

The DRE is less effective than the PSA blood test in finding prostate cancer, but it can sometimes find cancers in men with normal PSA levels. For this reason, ACS guidelines recommend that when prostate cancer screening is done, both the DRE and the PSA should be used. The DRE is also used once a man is known to have prostate cancer. It can help tell whether the cancer has spread beyond his prostate gland. It can also be used to find cancer that has come back after treatment.

Transrectal ultrasound (TRUS)

Transrectal ultrasound (TRUS) uses sound waves to make an image of the prostate on a video screen. For this test, a small probe is placed in the rectum. It gives off sound waves, which enter the prostate and create echoes that are picked up by the probe. A computer turns the pattern of echoes into a black and white picture of the prostate.

The test takes only a few minutes. You will feel some pressure when the TRUS probe is placed in your rectum, but it is usually not painful. TRUS is most commonly used during a prostate biopsy to guide the biopsy needles into the right area of the prostate.

If cancer is suspected

Signs that may be prostate cancer

Early prostate cancer often causes no symptoms. It may be found by a PSA test or DRE. Problems with urinating could be a sign of advanced prostate cancer. But more often this problem is caused by a less serious disease known as BPH (benign prostatic hyperplasia).

Symptoms of advanced prostate cancer could include the following:

• trouble having or keeping an erection (impotence)
• blood in the urine
• pain in the spine, hips, ribs, or other bones
• weakness or numbness in the legs or feet
• loss of bladder or bowel control

Once again, other diseases also can cause these symptoms.

If certain symptoms or the results of early tests suggest you might have prostate cancer, your doctor will do a prostate biopsy to find out whether the disease is present.

The prostate biopsy

A biopsy is the only way to know for sure if you have prostate cancer. During a biopsy, tissue from your prostate is removed so it can be sent to the lab to see if it contains cancer cells. A core needle biopsy is type used most often. Here is how it's done:

A small probe is placed in the rectum. The probe gives off sound waves which make a picture of the prostate on a video screen. This technique is called TRUS (transrectal ultrasound). Guided by TRUS, the doctor places a thin needle through the wall of the rectum into the prostate gland. When the needle is pulled out, it takes out a piece of tissue, usually about ½ inch long and 1/16 inch across. Some doctors do the biopsy through the skin between the rectum and the scrotum.

Although the test sounds painful, it usually causes little discomfort because it is done very quickly. The doctor can numb the area ahead of time. You might want to ask your doctor about numbing the area. Several samples are often taken from different parts of the prostate. Ask your doctor how many samples will be taken.

The biopsy takes about 15 minutes and is usually done in the doctor's office. You will likely be given antibiotics to take ahead of time and afterwards to reduce the chance of infection. For a few days afterwards you may notice some soreness, blood in your urine, or light bleeding from the rectum. Some men also have blood in their semen for a month or 2 after the biopsy.

Cancer may only be present in a small area of the prostate. Because of this, sometimes the biopsy will miss the cancer even when it is there. This is known as a "false negative." If your biopsy doesn't show cancer, but your doctor still strongly suspects cancer, a repeat biopsy may be needed.

Grading the prostate cancer

The biopsy sample will be sent to a lab. A doctor there will look for cancer cells in the sample. If cancer is present, the sample will be graded. Grading the cancer helps to predict how fast the cancer is likely to grow and spread.

Prostate cancers are graded on the basis of how closely the cells in the sample look like normal prostate cells. Those that look very different from normal cells are likely to mean a cancer that grows faster. The system used most often for grading prostate cancer is called the Gleason system.

Samples from 2 areas of the prostate are each graded from 1 to 5, and the number grades are added to give a Gleason score or sum of between 2 and 10. The lower the number, the more the cells in the sample look like normal prostate cells. A higher score means the cells look less normal and the cancer is likely to grow more quickly. Ask your doctor to explain the grade of your tumor because it is an important factor in making treatment decisions.

Sometimes the cells don't look like cancer but they don't look really normal either. In these cases, more biopsies may be done later.

Other things you may see on a biopsy report

The bopsy report tells you the grade of the cancer (if it is present), but it also often gives you other pieces of information that may give a better idea of the scope of the cancer. These can include:

• the number of biopsy samples that contain cancer (for example, "7 out of 12")
• the amount of cancer in each of the cores (given as a percentage)
• whether the cancer is on one side (left or right) of the prostate or both sides (bilateral)

Last Medical Review: 09/26/2008
Last Revised: 11/12/2008